Literature DB >> 10965495

Different roles of the CD2 and LFA-1 T-cell co-receptors for regulating cytotoxic, proliferative, and cytokine responses of human V gamma 9/V delta 2 T cells.

P Wang1, M Malkovsky.   

Abstract

BACKGROUND: Human V gamma 9/V delta 2 T lymphocytes recognize nonpeptidic antigens in a manner distinct from the classical antigen recognition by alpha beta T cells. The apparent lack of major histocompatibility (MHC) restriction and antigen processing allows very fast responses against pathogenic insults. To address the potential functional requirement for accessory molecules, we investigated the roles of the CD2 and lymphocyte function-associated antigen (LFA)-1 T-cell co-receptors in antigen-induced activities of human V gamma 9/V delta 2 T-cell clones.
MATERIALS AND METHODS: Human peripheral blood V gamma 9/V delta 2 T lymphocytes were cloned and their cytotoxicity against Daudi lymphoma was measured by a standard 51Cr-release assay. The responses of V gamma 9/V delta 2 T lymphocytes to nonpeptidic antigens were assessed using DNA synthesis and cytokine ELISA assays. Monoclonal antibodies specific for various molecules with potential T-cell accessory functions were utilized in blocking assays.
RESULTS: All of our V gamma 9/V delta 2 T-cell clones displayed the Th1 phenotype. The anti-LFA-1 antibody strongly inhibited the cytotoxicity of V gamma 9/V delta 2 T cells against Daudi B-cell lymphoma; whereas, it had no influence on the antigen-induced cytokine release or proliferation. In contrast, antibodies against CD2 and LFA-3 had no effect on the lytic activity of V gamma 9/V delta 2 T cells, but strongly inhibited the cytokine release and proliferation. However, the CD2-LFA-3 interaction was not an absolute requirement for the cytokine release and the DNA synthetic activity of antigen-stimulated V gamma 9/V delta 2 T cells, since the inhibitory effect could be reversed by addition of exogenous interleukin 2 (IL-2).
CONCLUSIONS: These novel observations indicate that the signals generated by different accessory molecules and IL-2 can contribute in an integrated fashion to the regulation of V gamma 9/V delta 2 T cells. These interactions may be important for the effectiveness of V gamma 9/V delta 2 T-cell responses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10965495      PMCID: PMC1949941     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  7 in total

Review 1.  Searching for "signal 2": costimulation requirements of γδ T cells.

Authors:  Julie C Ribot; Ana debarros; Bruno Silva-Santos
Journal:  Cell Mol Life Sci       Date:  2011-05-04       Impact factor: 9.261

Review 2.  Engineering γδ T Cells: Recognizing and Activating on Their Own Way.

Authors:  Ruoyu Dong; Yixi Zhang; Haowen Xiao; Xun Zeng
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

Review 3.  Integral Roles for Integrins in γδ T Cell Function.

Authors:  Gabrielle M Siegers
Journal:  Front Immunol       Date:  2018-03-13       Impact factor: 7.561

4.  TGF-β1 potentiates Vγ9Vδ2 T cell adoptive immunotherapy of cancer.

Authors:  Richard E Beatson; Ana C Parente-Pereira; Leena Halim; Domenico Cozzetto; Caroline Hull; Lynsey M Whilding; Olivier Martinez; Chelsea A Taylor; Jana Obajdin; Kim Ngan Luu Hoang; Benjamin Draper; Ayesha Iqbal; Tom Hardiman; Tomasz Zabinski; Francis Man; Rafael T M de Rosales; Jinger Xie; Fred Aswad; Daniela Achkova; Chung-Yang Ricardo Joseph; Sara Ciprut; Antonella Adami; Helge G Roider; Holger Hess-Stumpp; Balázs Győrffy; Jelmar Quist; Anita Grigoriadis; Anette Sommer; Andrew N J Tutt; David M Davies; John Maher
Journal:  Cell Rep Med       Date:  2021-12-21

5.  T Cell Integrin Overexpression as a Model of Murine Autoimmunity.

Authors:  Raymond L. Yung; Donna Ray; Ru Ran Mo; Jun Chen
Journal:  Biol Proced Online       Date:  2003-10-24       Impact factor: 3.244

Review 6.  Dual Face of Vγ9Vδ2-T Cells in Tumor Immunology: Anti- versus Pro-Tumoral Activities.

Authors:  Zheng Xiang; Wenwei Tu
Journal:  Front Immunol       Date:  2017-08-28       Impact factor: 7.561

7.  Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer.

Authors:  Yan Xu; Zheng Xiang; Mohammed Alnaggar; Léonce Kouakanou; Jiawei Li; Junyi He; Jiashuang Yang; Yi Hu; Yan Chen; Li Lin; Jianlei Hao; Jingxia Li; Jibing Chen; Man Li; Qingling Wu; Christian Peters; Qinghua Zhou; Jianshuang Li; Yingqing Liang; Xiaohua Wang; Baohui Han; Meili Ma; Dieter Kabelitz; Kecheng Xu; Wenwei Tu; Yangzhe Wu; Zhinan Yin
Journal:  Cell Mol Immunol       Date:  2020-09-16       Impact factor: 22.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.